Navigation Links
NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance
Date:11/1/2007

third quarter of 2007 were $1.0 million compared to $2.2 million for the same period in the prior year. Restructuring charges in 2007 relate primarily to initiatives to restructure operations announced in March 2007 while restructuring charges in 2006 related to initiatives to restructure operations announced in June 2006.

In the third quarter of 2007, NPS sold its rights to the PREOTACT royalty to Drug Royalty Corporation for $50 million up-front with an additional $25 million to be paid upon the achievement of certain revenue milestones. Although the sale is non recourse, under U.S. generally accepted accounting pronouncements this transaction will be treated as debt. NPS also issued $100 million of non recourse Sensipar backed B bonds, and issued $50 million of new 5.75% convertible debt due 2014. In the third quarter, NPS repurchased $20.2 million of 3% Convertible Notes due 2008 for $19.5 million.

As of September 30, 2007, the company had 46.4 million shares outstanding and $302.2 million in cash, cash equivalents and marketable investment securities as compared to $146.2 million at December 31, 2006.

NPS PHARMACEUTICALS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006

Revenues $29,161 $10,071 $52,267 $24,436

Operating expenses

Cost of goods sold 823 536 2,875 902

Cost of royalties 1,228 796 3,363 1,954

Research and

development 5,400 13,692 28,121 55,076

Selling, general

and administrative 5
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Scientific Corporation (NYSE: BSX ) today announced ... aggregate principal amount of its senior notes under the ... of $850 million of 4.50 percent notes due January ... 2020 and $300 million of 7.375 percent notes due ... net proceeds for general corporate purposes, including prepaying its ...
(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...
(Date:12/11/2009)... 11 EntreMed, Inc. (Nasdaq: ENMD ... in royalty revenue from sales of Thalomid® during ... of $3.3 million. In addition, the Company ... revenue for fiscal 2009. The difference in ... will be reflected in the fourth quarter financial ...
(Date:12/11/2009)... -- Researchers have discovered a new explanation for differences in ... copies of a certain gene, the more serious the handicap. ... is suspected that it is the amount of copies of ... published in the American Journal of Human Genetics , ... Guy Froyen connected to VIB, a life sciences research institute ...
Breaking Biology Technology:Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2Amount of gene surplus determines severity of mental retardation in males 2
... Scientific Dharmacon siRNA, to Identify 273 Human Proteins Needed for ... ... Causes AIDS, WALTHAM, Mass., Jan. 31 Thermo Fisher,Scientific ... (RNAi) technology has enabled a groundbreaking study,at Harvard Medical School in ...
... - Conference call webcast Thursday, January 31, 2008, 8:30 a.m. EST ... ... Jan. 31 Isis,Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today ... an Isis subsidiary.,The investment will allow Ibis to further develop the ...
... latest to report patient benefits, SUNNYVALE, Calif., ... company, today announced that it has extended,worldwide distribution ... America, Europe, the Middle East, Africa, and Asia ... for a wide variety,of surgical procedures., Sealing ...
Other Biology Technology:Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 2Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 3Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 4Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs 5Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 2Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 3Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 4Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology 2
(Date:12/15/2009)... model organism, but there are currently few resources ... blood-forming tissues in this species. A newly ... from Cold Spring Harbor Laboratory Press fills this ... protocols for the preparation, enumeration, and microscopic examination ... tissues in the mouse. The laboratory manual ...
(Date:12/14/2009)... often promoted as a clean-burning, renewable fuel that could ... health problems caused by ozone, compared with gasoline, especially ... Stanford researchers. , Ozone production from both gasoline ... is 85 percent ethanol, is greater in warm sunny ... of winter, because heat and sunlight contribute to ozone ...
(Date:12/14/2009)... team of researchers from the Astrobiology Centre (INTA-CSIC) has ... essential to the formation of the most basic biological ... In order to carry out this study, published in ... recreated the chemical conditions of the early Earth. , ... in ammoniac solutions it produces hydrogen cyanide, a substance ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3Prussian blue linked to the origin of life 2Allied World to Present at the 2009 Goldman Sachs U S Financial Services Conference 62660 1Allied World to Present at the 2009 Goldman Sachs U S Financial Services Conference 62660 2Healthcare Trust of America Inc Executes Agreement to Acquire a 92 500 Square Foot Medical Office Portfolio Located in Texas and Indiana 62658 1Healthcare Trust of America Inc Executes Agreement to Acquire a 92 500 Square Foot Medical Office Portfolio Located in Texas and Indiana 62658 2BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors Informational and Educational Use 62656 1BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors Informational and Educational Use 62656 2
... cells are necessary for successful animal cloning, proving instead that ... only can be used for cloning purposes, but they may ... researchers report they created two mouse pups from a type ... produce a second generation of its own kind. , ...
... in three doctors agree that free drug samples influence ... in the Journal of Medical Ethics. , But they ... be influenced by incentives than they are, the data ... 397 members of the American College of Obstetricians and ...
... inflammatory bone disease, may be a sign of faster "biological ... of the Rheumatic Diseases. , The authors base their findings ... and 79. Most of them were female twins. , X-rays ... for signs of osteoarthritis and a blood sample was taken ...
Other Biology News:Cloned mice created from fully differentiated cells, a milestone in cloning research 2Cloned mice created from fully differentiated cells, a milestone in cloning research 3Cloned mice created from fully differentiated cells, a milestone in cloning research 4Free drug samples influence prescribing, say one in three doctors 2Osteoarthritis may be sign of faster 'biological ageing' 2
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
The F40 pump maintenance kit is used to service one F40 pump of a BioLogic DuoFlow workstation. It includes 2 piston seals, 4 check valves, seal removal tool, and 2 O-rings....
Mouse monoclonal antibody raised against a partial recombinant EOMES. NCBI Entrez Gene ID = EOMES...
... antibody raised against a partial ... Immunogen: SLC22A3 (NP_068812, 90 ... recombinant protein with GST tag. ... NM_021977 ...
Biology Products: